These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7194744)

  • 1. Renal toxicity studies of protein-bound platinum(cis).
    Cole WC; Wolf W
    Chem Biol Interact; 1981 Jun; 35(3):341-8. PubMed ID: 7194744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
    Jones MM; Basinger MA; Mitchell WM; Bradley CA
    Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison in rodents of renal and intestinal toxicity of cisplatin and a new water-soluble antitumor platinum complex: N-methyl-iminodiacetato-diaminocyclohexane platinum (II).
    Newman RA; Khokhar AR; Sunderland BA; Travis EL; Bulger RE
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):454-63. PubMed ID: 3726868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of elastase on cis-platinum-induced renal toxicity.
    Suzuki M; Sekiguchi I; Tamada T; Tsuru S
    Oncology; 1991; 48(6):474-9. PubMed ID: 1749585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS; Riviere JE
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and biochemical assessment of kidney damage in albino wistar rats treated with cytotoxic platinum compounds in combination with 5-FU.
    Bano N; Ikram R
    Pak J Pharm Sci; 2017 Sep; 30(5):1595-1601. PubMed ID: 29084678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
    Cacini W; Harden EA; Skau KA
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
    Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
    Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of CV247 against cisplatin nephrotoxicity in rats.
    Máthé C; Szénási G; Sebestény A; Blázovics A; Szentmihályi K; Hamar P; Albert M
    Hum Exp Toxicol; 2014 Aug; 33(8):789-99. PubMed ID: 23653282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase).
    McGinness JE; Proctor PH; Demopoulos HB; Hokanson JA; Kirkpatrick DS
    Physiol Chem Phys; 1978; 10(3):267-77. PubMed ID: 733940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.
    Levi J; Jacobs C; Kalman SM; McTigue M; Weiner MW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):545-50. PubMed ID: 7193725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of some aspects of cis-platinum nephrotoxicity.
    Jones MM; Basinger MA; Craft WD; Domingo JL; Llobet JM
    Arch Toxicol; 1986 Oct; 59(3):167-71. PubMed ID: 3028320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological study of human cisplatin nephropathy.
    Tanaka H; Ishikawa E; Teshima S; Shimizu E
    Toxicol Pathol; 1986; 14(2):247-57. PubMed ID: 3764321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
    Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
    Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of cisplatin-induced renal and hepatic side effects in rat through antioxidative and anti-inflammatory properties of Malva sylvestris L. extract.
    Mohamadi Yarijani Z; Godini A; Madani SH; Najafi H
    Biomed Pharmacother; 2018 Oct; 106():1767-1774. PubMed ID: 30119252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin.
    Takahashi K; Seki T; Nishikawa K; Minamide S; Iwabuchi M; Ono M; Nagamine S; Horinishi H
    Jpn J Cancer Res; 1985 Jan; 76(1):68-74. PubMed ID: 3918912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity, nephrotoxicity, and drug/chemical interaction toxicity of platinum nanoparticles in mice.
    Isoda K; Daibo T; Yushina K; Yoshioka Y; Tsutsumi Y; Akimoto Y; Kawakami H; Taira Y; Taira I; Yanoshita R; Nishimura T; Ishida I
    Pharmazie; 2017 Jan; 72(1):10-16. PubMed ID: 29441891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.